These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9763587)

  • 1. High risk of chronic graft-versus-host disease in unmanipulated allogeneic peripheral blood stem cell transplantation.
    Kalayoğlu-Beşişik S; Budak-Alpdoğan T; Nuri Yenerel M; Sargin D; Tangün Y
    Blood; 1998 Oct; 92(8):2973-5. PubMed ID: 9763587
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?
    Haen SP; Pham M; Faul C; Dörfel D; Vogel W; Kanz L; Bethge WA
    Blood Cancer J; 2016 Jul; 6(7):e443. PubMed ID: 27391575
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
    Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
    Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease.
    Hueso T; Gauthier J; Joncquel Chevalier-Curt M; Magro L; Coiteux V; Dulery R; Carpentier B; Labreuche J; Damaj G; Yakoub-Agha I; Seguy D
    Clin Gastroenterol Hepatol; 2018 Jun; 16(6):908-917.e2. PubMed ID: 29258901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation.
    Agrawal N; Aggarwal M; Kapoor J; Ahmed R; Shrestha A; Kaushik M; Bhurani D
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29064140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
    Marr KA; Carter RA; Boeckh M; Martin P; Corey L
    Blood; 2002 Dec; 100(13):4358-66. PubMed ID: 12393425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience.
    Andreini A; Zampieri N; Costantini C; Malerba G; Bruno C; Salvagno G; Francia G; Gottardi M; Rimondini M; Ferrarini I; Lippi G; Ambrosetti A; Benedetti F; Tecchio C
    Leuk Lymphoma; 2018 Nov; 59(11):2719-2722. PubMed ID: 29561209
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults.
    Mehta RS; Peffault de Latour R; DeFor TE; Robin M; Lazaryan A; Xhaard A; Bejanyan N; de Fontbrune FS; Arora M; Brunstein CG; Blazar BR; Weisdorf DJ; MacMillan ML; Socie G; Holtan SG
    Haematologica; 2016 Jun; 101(6):764-72. PubMed ID: 27036159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: an update.
    Vigorito AC; Marques Júnior JF; Aranha FJ; Oliveira GB; Miranda EC; De Souza CA
    Haematologica; 2001 Jun; 86(6):665-6. PubMed ID: 11418381
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mucositis after allogeneic stem cell transplantation: Risk factors, clinical consequences and prophylaxis].
    Bourdelin M; Daguindau E; Larosa F; Legrand F; Nerich V; Deconinck E; Limat S
    Pathol Biol (Paris); 2015 Apr; 63(2):106-10. PubMed ID: 25555496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies.
    Huang W; Li H; Gao C; Bo J; Wang Q; Zhao Y; Jing Y; Wang S; Zhu H; Dou L; Wang L; Yu L
    Transfusion; 2012 Jun; 52(6):1354-62. PubMed ID: 22233440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
    Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia.
    Lv M; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X; Mo X
    Front Med; 2019 Dec; 13(6):667-679. PubMed ID: 31512033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
    Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
    Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease.
    Gjærde LK; Schmidt M; Sengeløv H
    Bone Marrow Transplant; 2018 Aug; 53(8):1061-1064. PubMed ID: 29491465
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive fungal disease is associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplant: a single center, retrospective study.
    Jin H; Fan Z; Huang F; Chai Y; Xuan L; Lin R; Xu N; Ye J; Sun J; Liu Q
    Infection; 2019 Apr; 47(2):275-284. PubMed ID: 30734248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
    Bensinger WI; Martin PJ; Storer B; Clift R; Forman SJ; Negrin R; Kashyap A; Flowers ME; Lilleby K; Chauncey TR; Storb R; Appelbaum FR
    N Engl J Med; 2001 Jan; 344(3):175-81. PubMed ID: 11172139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
    Olsson RF; Logan BR; Chaudhury S; Zhu X; Akpek G; Bolwell BJ; Bredeson CN; Dvorak CC; Gupta V; Ho VT; Lazarus HM; Marks DI; Ringdén OT; Pasquini MC; Schriber JR; Cooke KR
    Leukemia; 2015 Aug; 29(8):1754-62. PubMed ID: 25772027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.